
Positive interim data announced in clinical trial of POI treatment
Life sciences company Orexa has announced positive interim data for its Phase II trial evaluating ORE-001, a treatment for the prevention of post-operative ileus (POI) in patients undergoing major abdominal surgery. Interim analysis was conducted after 40 patients were randomised. The data demonstrated that ORE-001 could be… Read More

